Prostate Cancer Imaging Workshop In conjunction with MICCAI 2011 When: September 22, 2011 Where: Toronto, Canada CALL FOR PAPERS: Prostatic adenocarcinoma (CAP) is the second most common malignancy and the most frequently diagnosed cancer among men, with an estimated 190,000 new cases in the USA in 2010 (Source: American Cancer Society). September is prostate cancer awareness month, and we will be holding this workshop to discuss the latest prostate cancer imaging research. If CAP is detected early, men have a high five-year survival rate. Unfortunately, there is no standardized image-based screening protocol for early detection of CAP (unlike for breast cancers). In the USA high levels of prostate-specific antigen (PSA) warrant a trans-rectal ultrasound (TRUS) biopsy to enable histologic confirmation of presence or absence of CAP. TRUS biopsy incorporates significant random and systematic error. Random error occurs because the prostate is biopsied without knowledge of the cancer location; systematic error because certain areas (apex, transition zone, anterior fibrostroma) are under-sampled. There have been recent rapid developments in multi-parametric radiological imaging techniques (spectroscopy, dynamic contrast enhanced MR imaging, diffusion-weighting, PET, and ultrasound), that allow high resolution functional and metabolic imaging of benign and malignant prostate tissue. Distinct computational and technological challenges for multi-modal data registration and classification still remain in leveraging these multi-parametric data for optimizing biopsy and directing therapy. We invite submissions that address specific problems related to technologies for early detection, diagnosis, prognosis, and image guided interventions for treatment and biopsy of prostate cancer. Topics of interest include, but are not limited to: - Image Segmentation, Registration of Multi-parametric MRI and 2D/3D ultrasound - Validation of prostate segmentation and classification with registered 3D histological images - Shape analysis and morphology in prostate imaging - Optimizing image-guided targeted prostate cancer diagnosis and computer-aided detection, diagnosis - Robot assisted prostate interventions, Radiation therapy planning and guidance PLENARY SPEAKERS Professor Masoom A. Haider, MD, Department of Radiation Oncology, University of Toronto ( http://www.radonc.utoronto.ca/our-community/faculty/faculty-profiles/haider-masoom ) Assoc. Professor David A. Jaffray, PhD, Department of Medical Biophysics, University of Toronto, Head, Radiation Physics Department, Princess Margaret Hospital ( http://www.uhnresearch.ca/researchers/profile.php?lookup=2716 ) SUBMISSION OF PAPERS: Two types of submissions are encouraged (a) Regular papers (8-12 pages), and (b) Abstracts (up to 2 pages). The abstract styled submission is specifically to encourage clinicians and MD to participate in this workshop. All submissions (regular or abstract) may be submitted through the workshop website ( http://lcib.rutgers.edu/pci2011/ ), which and should conform to the MICCAI formatting instructions: (i) Papers should be in the LNCS style and submitted in PDF format, and (ii) anonymized for double blind review. Proceedings from last year’s workshop (Beijing) are available at http://www.amazon.com/Prostate-Cancer-Imaging-Computer-Aided-International/dp/3642159885 . IMPORTANT DATES: Paper submission deadline: June 8, 2011 Acceptance Notification: July 1, 2011 Submission of the camera-ready papers: July 9, 2011 ORGANIZERS: Anant Madabhushi (Rutgers University) Henkjan Huisman (Radboud University Nijmegen Medical Centre) Dean Barratt (University College London) Jason Dowling (CSIRO Australian e-Health Research Center) -------------------------------------------------------------------------